Neurable Raises $35M Series A for Non-Invasive BCI Signal Processing Platform
Summary
Neurable has closed a $35 million Series A round led by Spectrum Moonshot Fund to accelerate commercialization of Neurable AI, the company's patented compact brain-signal processing technology. The round brings total funding to $65 million. Neurable recently introduced the MW75 Neuro LT headphones along with an updated app providing real-time cognitive insights on mental fatigue, cognitive recovery, and focus state detection. The company is transitioning to a licensing platform model allowing global OEM partners to integrate BCI capabilities into consumer wearables.
Why it matters
Neurable's licensing platform strategy represents a potentially more scalable approach to consumer BCI than building proprietary hardware alone. By making its signal processing technology available to any OEM, Neurable could accelerate adoption of brain-computer interfaces across multiple device categories. The $35M Series A in a challenging funding environment demonstrates that non-invasive BCI with demonstrated signal quality and consumer appeal can still attract significant venture investment.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial